MRI-guided prostate adaptive radiotherapy - A systematic reviewCitation formats

  • Authors:
  • Andrew Mcpartlin
  • X. A. Li
  • Lucy Kershaw
  • Uulke A van der Heide
  • L Kerkmeijer
  • C Lawton
  • Usman Mahmood
  • Floris J Pos
  • N Van As
  • Marcel Van Herk
  • D Vesprini
  • J van der Voort van Zyp
  • A Tree
  • Ananya Choudhury
  • MR-Linac consortium

Standard

MRI-guided prostate adaptive radiotherapy - A systematic review. / Mcpartlin, Andrew; Li, X. A.; Kershaw, Lucy; van der Heide, Uulke A; Kerkmeijer, L; Lawton, C; Mahmood, Usman; Pos, Floris J; Van As, N; Van Herk, Marcel; Vesprini, D; van der Voort van Zyp, J; Tree, A; Choudhury, Ananya; MR-Linac consortium.

In: Radiotherapy and Oncology, Vol. 119, No. 3, 06.2016, p. 371-380.

Research output: Contribution to journalArticle

Harvard

Mcpartlin, A, Li, XA, Kershaw, L, van der Heide, UA, Kerkmeijer, L, Lawton, C, Mahmood, U, Pos, FJ, Van As, N, Van Herk, M, Vesprini, D, van der Voort van Zyp, J, Tree, A, Choudhury, A & MR-Linac consortium 2016, 'MRI-guided prostate adaptive radiotherapy - A systematic review' Radiotherapy and Oncology, vol. 119, no. 3, pp. 371-380. https://doi.org/10.1016/j.radonc.2016.04.014

APA

Mcpartlin, A., Li, X. A., Kershaw, L., van der Heide, U. A., Kerkmeijer, L., Lawton, C., ... MR-Linac consortium (2016). MRI-guided prostate adaptive radiotherapy - A systematic review. Radiotherapy and Oncology, 119(3), 371-380. https://doi.org/10.1016/j.radonc.2016.04.014

Vancouver

Mcpartlin A, Li XA, Kershaw L, van der Heide UA, Kerkmeijer L, Lawton C et al. MRI-guided prostate adaptive radiotherapy - A systematic review. Radiotherapy and Oncology. 2016 Jun;119(3):371-380. https://doi.org/10.1016/j.radonc.2016.04.014

Author

Mcpartlin, Andrew ; Li, X. A. ; Kershaw, Lucy ; van der Heide, Uulke A ; Kerkmeijer, L ; Lawton, C ; Mahmood, Usman ; Pos, Floris J ; Van As, N ; Van Herk, Marcel ; Vesprini, D ; van der Voort van Zyp, J ; Tree, A ; Choudhury, Ananya ; MR-Linac consortium. / MRI-guided prostate adaptive radiotherapy - A systematic review. In: Radiotherapy and Oncology. 2016 ; Vol. 119, No. 3. pp. 371-380.

Bibtex

@article{ab86bd4cbdbe41f0af664a0d4811f3e6,
title = "MRI-guided prostate adaptive radiotherapy - A systematic review",
abstract = "Dose escalated radiotherapy improves outcomes for men with prostate cancer. A plateau for benefit from dose escalation using EBRT may not have been reached for some patients with higher risk disease. The use of increasingly conformal techniques, such as step and shoot IMRT or more recently VMAT, has allowed treatment intensification to be achieved whilst minimising associated increases in toxicity to surrounding normal structures. To support further safe dose escalation, the uncertainties in the treatment target position will need be minimised using optimal planning and image-guided radiotherapy (IGRT). In particular the increasing usage of profoundly hypo-fractionated stereotactic therapy is predicated on the ability to confidently direct treatment precisely to the intended target for the duration of each treatment. This article reviews published studies on the influences of varies types of motion on daily prostate position and how these may be mitigated to improve IGRT in future. In particular the role that MRI has played in the generation of data is discussed and the potential role of the MR-Linac in next-generation IGRT is discussed.",
author = "Andrew Mcpartlin and Li, {X. A.} and Lucy Kershaw and {van der Heide}, {Uulke A} and L Kerkmeijer and C Lawton and Usman Mahmood and Pos, {Floris J} and {Van As}, N and {Van Herk}, Marcel and D Vesprini and {van der Voort van Zyp}, J and A Tree and Ananya Choudhury and {MR-Linac consortium}",
note = "Copyright {\circledC} 2016 Elsevier Ireland Ltd. All rights reserved.",
year = "2016",
month = "6",
doi = "10.1016/j.radonc.2016.04.014",
language = "English",
volume = "119",
pages = "371--380",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier BV",
number = "3",

}

RIS

TY - JOUR

T1 - MRI-guided prostate adaptive radiotherapy - A systematic review

AU - Mcpartlin, Andrew

AU - Li, X. A.

AU - Kershaw, Lucy

AU - van der Heide, Uulke A

AU - Kerkmeijer, L

AU - Lawton, C

AU - Mahmood, Usman

AU - Pos, Floris J

AU - Van As, N

AU - Van Herk, Marcel

AU - Vesprini, D

AU - van der Voort van Zyp, J

AU - Tree, A

AU - Choudhury, Ananya

AU - MR-Linac consortium

N1 - Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

PY - 2016/6

Y1 - 2016/6

N2 - Dose escalated radiotherapy improves outcomes for men with prostate cancer. A plateau for benefit from dose escalation using EBRT may not have been reached for some patients with higher risk disease. The use of increasingly conformal techniques, such as step and shoot IMRT or more recently VMAT, has allowed treatment intensification to be achieved whilst minimising associated increases in toxicity to surrounding normal structures. To support further safe dose escalation, the uncertainties in the treatment target position will need be minimised using optimal planning and image-guided radiotherapy (IGRT). In particular the increasing usage of profoundly hypo-fractionated stereotactic therapy is predicated on the ability to confidently direct treatment precisely to the intended target for the duration of each treatment. This article reviews published studies on the influences of varies types of motion on daily prostate position and how these may be mitigated to improve IGRT in future. In particular the role that MRI has played in the generation of data is discussed and the potential role of the MR-Linac in next-generation IGRT is discussed.

AB - Dose escalated radiotherapy improves outcomes for men with prostate cancer. A plateau for benefit from dose escalation using EBRT may not have been reached for some patients with higher risk disease. The use of increasingly conformal techniques, such as step and shoot IMRT or more recently VMAT, has allowed treatment intensification to be achieved whilst minimising associated increases in toxicity to surrounding normal structures. To support further safe dose escalation, the uncertainties in the treatment target position will need be minimised using optimal planning and image-guided radiotherapy (IGRT). In particular the increasing usage of profoundly hypo-fractionated stereotactic therapy is predicated on the ability to confidently direct treatment precisely to the intended target for the duration of each treatment. This article reviews published studies on the influences of varies types of motion on daily prostate position and how these may be mitigated to improve IGRT in future. In particular the role that MRI has played in the generation of data is discussed and the potential role of the MR-Linac in next-generation IGRT is discussed.

U2 - 10.1016/j.radonc.2016.04.014

DO - 10.1016/j.radonc.2016.04.014

M3 - Article

VL - 119

SP - 371

EP - 380

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

IS - 3

ER -